Home > Publications database > The Neuroscience Peer Review Consortium > print

001     4119
005     20180208222751.0
024 7 _ |2 DOI
|a 10.1016/j.neuropharm.2009.01.001
024 7 _ |2 WOS
|a WOS:000264519000001
037 _ _ |a PreJuSER-4119
041 _ _ |a eng
082 _ _ |a 610
084 _ _ |2 WoS
|a Neurosciences
084 _ _ |2 WoS
|a Pharmacology & Pharmacy
100 1 _ |a Saper, C.B.
|b 0
|0 P:(DE-HGF)0
245 _ _ |a The Neuroscience Peer Review Consortium
260 _ _ |a Amsterdam [u.a.]
|b Elsevier Science
|c 2009
300 _ _ |a 733 - 734
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Neuropharmacology
|x 0028-3908
|0 20481
|y 4
|v 56
500 _ _ |a Record converted from VDB: 12.11.2012
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science
650 _ 7 |a J
|2 WoSType
700 1 _ |a Maunsell, J.H.R.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Destexhe, A.
|b 2
|0 P:(DE-HGF)0
700 1 _ |a Richmond, B.
|b 3
|0 P:(DE-HGF)0
700 1 _ |a Campagnoni, A.
|b 4
|0 P:(DE-HGF)0
700 1 _ |a Sarter, M.
|b 5
|0 P:(DE-HGF)0
700 1 _ |a Fritschy, J.M.
|b 6
|0 P:(DE-HGF)0
700 1 _ |a Saper, C.
|b 7
|0 P:(DE-HGF)0
700 1 _ |a Bloom, F.E.
|b 8
|0 P:(DE-HGF)0
700 1 _ |a Perry, G.
|b 9
|0 P:(DE-HGF)0
700 1 _ |a Smith, M.A.
|b 10
|0 P:(DE-HGF)0
700 1 _ |a Maunsell, J.
|b 11
|0 P:(DE-HGF)0
700 1 _ |a Ascoli, G.A.
|b 12
|0 P:(DE-HGF)0
700 1 _ |a Kennedy, D.
|b 13
|0 P:(DE-HGF)0
700 1 _ |a De Schutter, E.
|b 14
|0 P:(DE-HGF)0
700 1 _ |a Eichenbaum, H.
|b 15
|0 P:(DE-HGF)0
700 1 _ |a Greenamyre, J.T.
|b 16
|0 P:(DE-HGF)0
700 1 _ |a Krystal, J.
|b 17
|0 P:(DE-HGF)0
700 1 _ |a Zilles, K.
|b 18
|u FZJ
|0 P:(DE-Juel1)131714
700 1 _ |a Zaborszky, L.
|b 19
|0 P:(DE-HGF)0
700 1 _ |a Byrne, J.H.
|b 20
|0 P:(DE-HGF)0
700 1 _ |a Blumberg, M.
|b 21
|0 P:(DE-HGF)0
700 1 _ |a Lumsden, A.
|b 22
|0 P:(DE-HGF)0
700 1 _ |a Harris, B.
|b 23
|0 P:(DE-HGF)0
700 1 _ |a Sanes, J.
|b 24
|0 P:(DE-HGF)0
700 1 _ |a Wong, R.
|b 25
|0 P:(DE-HGF)0
700 1 _ |a Eatock, R.A.
|b 26
|0 P:(DE-HGF)0
700 1 _ |a Gilman, S.
|b 27
|0 P:(DE-HGF)0
700 1 _ |a Lisberger, S.
|b 28
|0 P:(DE-HGF)0
700 1 _ |a Poznanski, R.R.
|b 29
|u FZJ
|0 P:(DE-Juel1)VDB84572
700 1 _ |a Simons, R.F.
|b 30
|0 P:(DE-HGF)0
700 1 _ |a Millar, R.
|b 31
|0 P:(DE-HGF)0
700 1 _ |a Fox, P.T.
|b 32
|0 P:(DE-HGF)0
700 1 _ |a Lancaster, J.
|b 33
|0 P:(DE-HGF)0
700 1 _ |a Fletcher, P.C.
|b 34
|0 P:(DE-HGF)0
773 _ _ |a 10.1016/j.neuropharm.2009.01.001
|g Vol. 56, p. 733 - 734
|p 733 - 734
|q 56<733 - 734
|0 PERI:(DE-600)1500655-4
|t Neuropharmacology
|v 56
|y 2009
|x 0028-3908
856 7 _ |u http://dx.doi.org/10.1016/j.neuropharm.2009.01.001
909 C O |o oai:juser.fz-juelich.de:4119
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2009
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INM-2
|l Molekulare Organisation des Gehirns
|g INM
|0 I:(DE-Juel1)INM-2-20090406
|x 0
970 _ _ |a VDB:(DE-Juel1)110794
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21